Results 61 to 70 of about 85,115,453 (207)
Frontiers in Endocrinology, 2023 BackgroundPreimplantation genetic testing for aneuploidy (PGT-A) is an emerging technology that aims to identify euploid embryos for transfer, reducing the risk of embryonic chromosomal abnormalities.
Zhuo Liang +25 more
doaj +1 more source
, 2019 Time-lapse microscopy was used to compare morphokinetic variables between expanded blastocysts derived from preimplantation genetic testing for aneuploidy cycles using high-resolution next-generation sequencing (hr-NGS).
Lee, C (via Mendeley Data) +1 more
core +1 more source
A deep dive into the morphokinetics and ploidy of low-quality blastocysts
F&S Reports, 2022 Objective: To describe morphokinetic parameters and ploidy among low-quality blastocysts not meeting the criteria for clinical use. Design: Prospective cohort study. Setting: Academic medical center.
Molly M. Quinn, M.D. +4 more
doaj +1 more source
The use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinion [PDF]
Fertility and Sterility, 2018 The value of preimplantation genetic testing for aneuploidy (PGT-A) as a screening test for in vitro fertilization (IVF) patients has yet to be determined. Several studies demonstrate higher birth rates after aneuploidy testing and elective single-embryo transfer (eSET), suggesting the potential for this testing to decrease the risk of multiple ...
Alan Penzias +20 more
openaire +2 more sources
Australian and New Zealand Journal of Obstetrics and Gynaecology, Volume 66, Issue 5, October 2026.ABSTRACT Background Intralipid is used as an adjunctive therapy in assisted reproductive technology (ART), but data regarding pregnancy outcomes and early placental biomarkers are limited. Aims To evaluate the association between Intralipid exposure during frozen embryo transfer (FET) cycles and pregnancy outcomes, birthweight and first‐trimester ...
Neerja Kamal +2 more
wiley +1 more source
Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 10, Page 1950-1964, October 2026.Prenatal exome sequencing significantly improves diagnostic yield over chromosomal microarray analysis for fetal CNS abnormalities, with a diagnostic yield of 16% in our cohort and 27% in the meta‐analysis. Diagnostic yields vary across different phenotypes. Abstract Introduction Fetal central nervous system (CNS) abnormalities have diverse etiologies,
Jia Yao +5 more
wiley +1 more source
Expert Review of Molecular Diagnostics, 2016 Preimplantation genetic diagnosis (PGD) was introduced as an alternative to prenatal diagnosis: embryos cultured in vitro were analysed for a monogenic disease and only disease-free embryos were transferred to the mother, to avoid the termination of pregnancy with an affected foetus.
openaire +3 more sources
Clinical and Translational Medicine, Volume 16, Issue 9, September 2026.Mature oocytes were subjected to cryopreservation followed by intracytoplasmic sperm injection (ICSI). Embryos at multiple developmental stages were collected, dissociated into single cells and processed for single‐cell library construction and bioinformatics analysis.
Yixin Ren +14 more
wiley +1 more source
, 2023 Aneuploidy in preimplantation embryos is a major cause of human reproductive failure. Unlike uniformly aneuploid embryos, embryos diagnosed as diploid-aneuploid mosaics after preimplantation genetic testing for aneuploidy (PGT-A) can develop into healthy
F. Dominguez (15288205) +9 more
core +1 more source
Clinical and Experimental Obstetrics & Gynecology, 2022 Background: This study aimed to compare the use of next-generation sequencing (NGS) and single-nucleotide polymorphism (SNP) array in preimplantation genetic testing for aneuploidy (PGT-A) in the same blastocyst.
Zhanhui Ou +3 more
doaj +1 more source